Viewing StudyNCT00003880

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00003880
Status: TERMINATED
Last Update Posted: 2015-04-16
First Post: 1999-11-01
Brief Title: Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Primary Peritoneal Cavity Cancer
Ovarian Cancer
Keywords:
Name View
primary peritoneal cavity cancer View
stage III ovarian epithelial cancer View
ovarian mixed epithelial carcinoma View
ovarian serous cystadenocarcinoma View
ovarian mucinous cystadenocarcinoma View
ovarian endometrioid adenocarcinoma View
ovarian clear cell cystadenocarcinoma View